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Genome sequencing of Mycobacterium tuberculosis complex members has accelerated the
search for new disease-control tools. Antigen mining is one area that has benefited enormously
from access to genome data. As part of an ongoing antigen mining programme, we screened
genes that were previously identified by transcriptome analysis as upregulated in response to an
in vitro acid shock for their in vivo expression profile and antigenicity. We show that the genes
encoding two methyltransferases, Mb1438c/Rv1403c and Mb1440c/Rv1404c, were highly
upregulated in a mouse model of infection, and were antigenic in M. bovis-infected cattle. As the
genes encoding these antigens were highly upregulated in vivo, we sought to define their genetic
regulation. A mutant was constructed that was deleted for their putative regulator, Mb1439/
Rv1404; loss of the regulator led to increased expression of the flanking methyltransferases and a
defined set of distal genes. This work has therefore generated both applied and fundamental
outputs, with the description of novel mycobacterial antigens that can now be moved into field
trials, but also with the description of a regulatory network that is responsive to both in vivo and in
vitro stimuli.
INTRODUCTION
Mycobacterium bovis is the causative agent of bovine
tuberculosis, a disease responsible for annual losses to
global agriculture of $3 billion and with serious repercus-
sions for public health and animal welfare. Control of
bovine tuberculosis in many countries involves regular
testing of cattle (skin test) with a crude preparation of
mycobacterial antigens termed PPD (purified protein
derivative, also known as tuberculin), followed by
compulsory slaughter of positive reactors. Vaccination is
not used as part of the control strategy since the only
available vaccine, the human tuberculosis vaccine bacille
Calmette–Guérin (BCG), imparts only limited protection in
cattle and compromises the use of the skin test. In order to
control bovine tuberculosis there is therefore an acute need
to develop both improved vaccines and diagnostic tests.
Antigens have already been identified that are feeding into
the design of new control strategies. The potent T-cell
antigens ESAT-6 and CFP-10 were originally identified
from Mycobacterium tuberculosis culture filtrates (Sørensen
et al., 1995; Skjøt et al., 2000), with the genes encoding
these antigens deleted from the genome of the BCG vaccine
strain (Mahairas et al., 1996). They therefore have obvious
application to the differential diagnosis of vaccination
versus infection. Similarly, antigens have been described
that impart significant levels of protection against challenge
when used as subunit vaccines (Ibanga et al., 2006; Orme,
2006; Vordermeier et al., 2006). However, we need to
expand our repertoire of known antigens to ensure that the
best candidates, or cocktails, are optimized and applied.
Abbreviations: IFN-c, gamma-interferon; PPD, purified protein derivative
(tuberculin); qRT-PCR, quantitative real-time polymerase chain reaction.
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One approach to the discovery of new antigens is to exploit
the information contained in the M. bovis genome.
Sequencing the M. bovis genome revealed ~4000 protein-
encoding genes (Garnier et al., 2003); however, it is not
feasible to screen all of these proteins for diagnostic or
vaccine potential. Instead a biologically relevant filter must
be used to sift the genome information to a manageable
subset. One subset of obvious interest would be genes that
are upregulated in vivo, but there are difficulties in
identifying global expression changes of M. bovis in cattle.
A parallel approach would be to identify genes that
respond in vitro to a surrogate of the in vivo milieu, such
as nutrient starvation, hypoxia or acid shock, and then to
screen the identified genes for their expression profile
responses in vivo using targeted methods. Following this
approach we chose acid as our in vitro surrogate and in
doing so found 60 M. bovis genes that were upregulated
when the bacteria were exposed to acid shock (Golby et al.,
2007).
In this study, we have determined whether in vitro acid-
induced genes are also upregulated in vivo, and then
screened the resulting candidates for their immunogenicity
in M. bovis-infected cattle. Using this approach, we have
identified two putative methyltransferase-encoding genes
which are highly upregulated in vivo and whose products
are immunogenic in cattle. We furthermore identified the
regulator of these methyltransferase genes as a route to
understanding their upregulation in vivo.
METHODS
Bacterial strains and growth conditions; gene designations. M.
bovis 2122/97 (Garnier et al., 2003) was routinely grown in
Middlebrook 7H9 broth supplemented with 10 % albumin-dex-
trose-catalase (ADC, Difco), 0.05 % Tween and 10 mM pyruvate, or
on 7H11 agar supplemented with 10 % oleic acid-albumin-dextrose-
catalase (OADC, Difco), and 10 mM pyruvate. Similar media were
used for the growth of M. tuberculosis H37Rv, except the pyruvate was
replaced with 0.2 % or 0.5 % glycerol for growth in liquid or on solid
media, respectively. Liquid cultures were grown at 37 uC in 2 l bottles
rotated at 2–3 r.p.m. Where used, hygromycin and kanamycin were
present at 150 mg ml21 and 50 mg ml21, respectively. For gene
designations, ‘Mb’ denotes a gene from M. bovis 2122, while ‘Rv’ is a
gene from M. tuberculosis H37Rv (Cole et al., 1998; Garnier et al.,
2003).
Extraction of RNA from mouse tissues and broth cultures.
Female BALB/c mice were intranasally infected with 200–300 c.f.u. of
M. bovis and euthanized when clinical signs of tuberculosis disease
became apparent. Lungs were removed from the mice, and for each
lung one half was placed in a vial containing 10 ml Trizol and the
other half in 10 ml phosphate-buffered saline solution (PBS) plus
0.05 % Triton X-100; then both vials were stored at –80 uC. When
required, the vials were thawed and the contents homogenized. The
Trizol-lung homogenate was transferred to Ribolyser tubes and RNA
extracted according to the protocol outlined by Bacon et al. (2004).
The PBS-lung homogenate was serially diluted and plated onto solid
growth medium. The plates were incubated at 37 uC for 3–4 weeks
before the numbers of M. bovis colonies were counted. Viable counts
were approximately 108–109 c.f.u. per lung.
RNA was prepared from broth cultures of M. tuberculosis and M. bovis
using the guanidinium thiocyanate procedure (Bacon et al., 2004).
Quantitative real-time PCR (qRT-PCR) experiments were performed
as described by Golby et al. (2007); the sequences of the primer pairs
are given in Supplementary Table S1, available with the online version
of this paper.
Antigen discovery. A set of 469 peptides spanning the lengths of 11
open reading frames were purchased from Mimitopes. The peptides
were 20 residues in length, each with a 12 residue overlap with its
neighbouring peptide. Peptides were formulated into pools of
approximately 8–12 peptides. The gamma-interferon (IFN-c)
immunoassay methodology was as described previously (Cockle
et al., 2002). For screening purposes, bloods were taken from 21
reactor cattle naturally infected with M. bovis. The IFN-c concentra-
tion was determined using the BOVIGAM ELISA kit (Prionics). An
antigen was defined as giving a positive response when the A450 with
antigen minus A450 without antigens was ¢0.1. Absorbance readings
were converted to concentration of IFN-c (pg ml21) using the
following equation: (A450630.9)+0.5658.
Construction of M. tuberculosis H37Rv Rv1403c–Rv1405c
deletion strain PG100. A 0.9 kb fragment containing the 59 ends
of the Mb1440c and fmt genes was PCR amplified using M. bovis 2122
chromosomal DNA and primers Mb1440c59F1 and Mb1440c59R.
(Sequences of primers used in the construction of plasmids and the
verification of the mutant are given in Supplementary Table S2.) The
PCR product was digested with BamHI and cloned into the ColE1
plasmid pSMT100, which contains a hygR cassette and the sacB gene,
to give the construct pPG28. A 0.9 kb fragment containing the 39 ends
of Rv1403c and priA was PCR amplified using primers Mb1438c39F
and Mb1438c39R1, digested with XbaI and PstI and cloned into
pPG28 to give pPG34 (Fig. 1). The plasmid was used to transform M.
tuberculosis H37Rv and transformants were plated onto 7H11
medium containing 0.5 % glycerol, OADC, 2 % sucrose and
hygromycin. Hygromycin- and sucrose-resistant colonies were
screened for loss of the Rv1403c–Rv1405c genes by PCR using
primers that anneal to the 59 end of Rv1405c and the 39 end of
Rv1403c. Putative DRv1403c–Rv1405c mutants were verified by PCR
using primers that anneal to internal sequences of the hygromycin-
resistance cassette and the fmt gene, hygF and fmtR1 respectively.
Construction of Rv1405c-, Rv1404- and Rv1403c-overexpres-
sing plasmids. The Rv1405c-overexpressing plasmid was prepared by
PCR amplification of a 1.4 kb fragment encompassing Rv1405c and
525 bp upstream of the initiation codon (fragment A, Fig. 1) using M.
tuberculosis H37Rv genomic DNA as a template and primers
Rv1405cF1 and Rv1405cR1. The PCR product was digested with
BamHI and cloned into BamHI-cut pMD31 (Donnelly-Wu et al., 1993)
to give plasmid pPG53 (Fig. 1). The Rv1403c-overexpresssing plasmid
was constructed by amplifying a 1.5 kb fragment encompassing
Rv1403c and 515 bp upstream of its start codon (fragment B, Fig. 1)
using primers Rv1403cF1 and Rv1403cR1. The product was digested
with BamHI and cloned into BamHI-cut pMD31 to give plasmid
pPG54. The construct overexpressing both Rv1405c and Rv1404 was
prepared by amplification of a 1 kb fragment containing Rv1404 and
456 bp upstream of the start codon (fragment C, Fig. 1) using primers
Rv1404F1 and Rv1404R1. The PCR product was digested with XbaI
and HindIII and cloned into the corresponding sites of plasmid pPG53
to give construct pPG55. Similarly, the Rv1403c- and Rv1404-contain-
ing plasmid was created by cloning the 1 kb Rv1404-containing PCR
fragment previously described into plasmid pPG54 to create the
construct pPG56. To construct the Rv1404-overexpressing plasmid
used in the microarray experiments the 1 kb XbaI–HindIII Rv1404-
containing fragment of pPG55 was cloned into the corresponding sites
of pMD31 to generate the construct pPG57. Plasmid pPG72, which
contains a 3 kb 9priA-Rv1403c-Rv1404-Rv1405c-fmt9 fragment, was
P. Golby and others
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constructed in several steps. Firstly, a 1.6 kb 9priA-Rv1403c-Rv1404-
Rv1405c9-containing fragment (fragment D, Fig. 1) was PCR amplified
using primers priAF and Rv1405cR3, and then a 1.4 kb 9Rv1405c-fmt9-
containing fragment (fragment E, Fig. 1) was amplified using primers
Rv1405cF2 and fmtR2. The two PCR fragments were digested with
HindIII and AfeI, and cloned into HindIII-cut pMD31 to yield pPG72.
Sequences of primers used in plasmid construction are given in
Supplementary Table S2.
Microarray analysis. Three independent experiments (biological
replicates) were carried out. For each strain in each experiment, two
microarrays (technical replicates) were performed, with each micro-
array having two measurements of every gene. Two colour
hybridizations were performed using whole-genome M. bovis/M.
tuberculosis microarrays; the array design is available in BmG@Sbase,
accession no. A-BUGS-31 (http://bugs.sgul.ac.uk/A-BUGS-31) and
also ArrayExpress, accession no. A-BUGS-31. Cy5 and Cy3 fluores-
cently labelled probes synthesized from RNA and genomic DNA,
respectively, were hybridized to microarrays. Further details concern-
ing the design of the microarrays and procedures used for probe
manufacture and hybridization can be found in Golby et al. (2007).
Scanning and image analysis. Microarrays were scanned using a
GenePix 4000A microarray scanner (Axon Instruments) with the
photomultiplier tube set in the range 550–750 V, so that spots with
the highest signal intensities were just below the level of saturation.
Fluorescent spots on each image were quantified using BlueFuse for
Microarrays software (BlueGnome).
Microarray data analysis. Data from every microarray were
normalized by calculating the log ratio of the Cy5 to Cy3 signal for
every spot, and then dividing each log ratio by the median of the log
ratios of all spots (excluding control spots) on the array. As an
additional normalization step, a median absolute deviation (MAD)
scale transformation was applied to the normalized data from the
previous step. For each microarray, duplicate spots were averaged,
and then the average expression of every gene across all technical
replicate microarrays was calculated. Averages of the three biological
replicates were used to compare gene expression between strains. For
each gene, a moderate t-test was applied and those genes with a P-
value less than 0.05 were selected. From this gene list, those genes
whose average expression differed by more than 3-fold between
strains were selected. Fully annotated microarray data have been
deposited in BmG@Sbase (accession number: E-BUGS-59; http://
bugs.sgul.ac.uk/E-BUGS-59) and also ArrayExpress (accession num-
ber: E-BUGS-59).
RESULTS
Analysis of in vivo gene expression by qRT-PCR
We previously described the effect of acid shock on the
transcriptome of M. bovis and M. tuberculosis grown in a
chemostat (Golby et al., 2007), and identified Mb1438c and
Mb1440c (and the M. tuberculosis orthologues Rv1403c and
Rv1405c, respectively) as two of the genes most highly
induced in response to acid shock. Both genes were
induced within 5 min of acid shock, and maintained high
expression over 24 h (Golby et al., 2007). However, the
Fig. 1. Schematic representation of the Rv1405c–Rv1403c genomic region. The direction of the arrows indicates the relative
direction of transcription for each gene. Restriction enzyme sites incorporated into the sequences of the PCR primers/products
are: H, HindIII; B, BamHI; X, XbaI; A, AfeI.
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question was whether this in vitro stress truly paralleled
stresses experienced by M. bovis and M. tuberculosis in vivo.
To determine whether in vitro acid-induced genes were also
upregulated in vivo we screened 26 acid-shock-induced
genes, selected on the basis of putative function and fold
change, by qRT-PCR to determine their gene expression in
vivo relative to an in vitro control (Table 1). The genes
Rv1403c/Mb1438c, Rv1404/Mb1439, Rv1405/Mb1440c and
11 of the other 26 genes were upregulated in vivo, with
Rv1405c/Mb1440c and Rv1403c/Mb1438c showing changes
in expression of 326- and 37-fold, respectively, in vivo
compared to in vitro (Table 1). The standard deviations for
each gene were high, reflecting the variability in gene
expression observed across different mice, but generally the
fold increases in expression were in agreement with
previous data on upregulation after acid shock (Golby
et al., 2007).
Antigen screening
We next determined whether in vivo-induced genes were
antigenic in the bovine host. We selected 11 of the in vivo-
upregulated genes, including the highly upregulated
Rv1403c/Mb1438c and Rv1405c/Mb1440c as well as their
putative regulator, Rv1404/Mb1439. Immunogenicity was
assessed using an IFN-c immunoassay using blood
obtained from cattle naturally infected with M. bovis.
Peptides derived from the sequences of the 11 CDS were
synthesized and pooled into 46 groups, with each group
consisting of 8–12 overlapping peptides (Table 2). Whole-
blood cultures in the presence of the peptide pools were
established and IFN-c production measured after 48 h of
culture. Fig. 2 shows the percentage of cattle tested thatTable 1. In vivo expression of acid-shock-induced genes
M. bovis CDS M. tuberculosis CDS Gene Fold change*
Mb0217 Rv0211 pckA 25.5±10
Mb0476 Rv0467 icl 18±19.2
Mb0529c Rv0516c NC
Mb1058 Rv1029 kdpA NC
Mb1086 Rv1057 8.4±4.7
Mb1162 Rv1131 gltA1 NC
Mb1214 Rv1182 papA3 NC
Mb1216c Rv1184c 7.3±2.8







Mb1788 Rv1758 cut1 2.7±1.1
Mb1803 Rv1774 NC
Mb2057c Rv2031c hspX 38.7±19.7
Mb2194c Rv2172c NC
Mb2364 Rv2336 NC
Mb2454 Rv2428 ahpC 4.1±1.9
Mb2587 Rv2557 NC
Mb2955 Rv2930 fadD26 NC
Mb3028c Rv3003c ilvB1 NC
Mb3116 Rv3089 fadD13 NC
Mb3163 Rv3139 fadE24 4.7±2.0
*Fold changes are the mean ratios±SD of expression measured in
mouse lung tissues compared with expression measured of in vitro-
grown M. bovis. NC, No change.











Mb1438c Rv1403c 274 1–3
Mb1439 Rv1404 160 4–5
Mb1440c Rv1405c 274 6–8
Mb0217 Rv0211 pckA 606 9–15
Mb0476 Rv0467 icl 428 16–20
Mb1788 Rv1758 cut1 218 21–23
Mb1217c Rv1185c fadD21 578 24–30
Mb3163 Rv3139 fadE24 468 31–36
Mb2454 Rv2428 ahpC 195 37–38
Mb1086 Rv1057 393 39–43
Mb1495 Rv1460 268 44–46
Fig. 2. Percentage of cattle that responded positively to antigens
tested. The dashed vertical line indicates the positive cutoff value
of 40 %. PPDA is purified protein derivative from M. avium, PPDB
is purified protein derivative from M. tuberculosis, and SEB is
staphylococcal enterotoxin B. Peptide pools giving positive
responses are pool 1 (Mb1438c/Rv1403c), pools 6 and 8
(Mb1440c/Rv1405c), pool 25 (FadD21) and pool 32 (FadE24).
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gave a positive response for each of the peptide pools
tested. All cattle showed a positive response to PPD from
M. avium (PPDA) and M. bovis (PPDB), as well as a
staphylococccal enterotoxin B control. Five of the peptide
pools tested showed a positive response in at least 40 % of
cattle tested, namely pools 1 (containing peptides from
Mb1438c), 6 and 8 (Mb1440c), 25 (FadD21) and 32
(FadE24), with Mb1438c being the strongest inducer of
IFN-c (Fig. 3). For diagnostic use, secreted antigens are of
particular interest as host responsiveness is indicative of
ongoing infection with viable bacilli. Furthermore, early
and sustained upregulation of genes Mb1440c and Mb1438c
in vivo points to their potential as subunit vaccines, as
responses seen early in infection may be associated with
protection.
Isolation of a DRv1403c–Rv1405c : : hyg mutant
The high degree of upregulation of the two putative
methyltransferase-encoding genes Mb1440c and Mb1438c
and the immunogenic properties of the corresponding
proteins prompted us to examine their regulation. Rv1404/
Mb1439 encodes a protein that has some homology to the
MarR family of transcriptional regulators, and we have
previously speculated that it could function to regulate the
expression of Rv1403c/Mb1438c and Rv1405c/Mb1440c
(Golby et al., 2007). In order to test this, we sought to
construct an Rv1404/Mb1439 deletion mutant. Attempts to
isolate a targeted deletion of Rv1404 using plasmid- or
bacteriophage-based mutagenesis systems proved unsuc-
cessful in M. bovis. We were, however, successful in
isolating a triple mutant of M. tuberculosis H37Rv in which
the genes Rv1403c, Rv1404 and Rv1405c were deleted and
replaced with a hygromycin-resistance cassette. The result-
ing strain was designated PG100. Allelic exchange of
Rv1403c-Rv1405c with the hygR resistance cassette in
PG100 was confirmed by PCR using primers that anneal
to the hygromycin-resistance cassette and the adjacent fmt
gene (Fig. 1).
Liquid culture growth experiments using PG100 showed
that it grew more slowly, and had a much greater tendency
to aggregate, than the wild-type (Fig. 4). The defective
growth phenotype of the mutant could only be partially
corrected by transformation with a plasmid (pPG72) that
contained the genes Rv1405c, Rv1404 and Rv1403c.
Transformation of the mutant with a plasmid over-
expressing Rv1404 alone (pPG57) conferred a similar level
of complementation to that seen with pPG72 (Fig. 4).
Complementation with Rv1404 had a similar effect to
addition of all three deleted genes, suggesting that the
PG100 growth defect was due to the loss of Rv1404 and not
Rv1405c or Rv1403c. However, failure to achieve full trans
complementation using the Rv1404 overexpression con-
struct suggests a complex regulatory circuit that may
require cis complementation.
Rv1404 is a transcriptional repressor of Rv1405c
and Rv1403c
qRT-PCR was used to study the effect of Rv1404 on the
expression of Rv1405c and Rv1403c in M. tuberculosis.
Fig. 3. IFN-c responses induced to antigens in M. bovis-infected
cattle. The results of those cattle that gave only a positive response
are shown. Horizontal lines indicate the mean IFN-c response for a
particular antigen pool. An antigen is defined as giving a positive
response when the A450 with antigen minus A450 without antigen
was ¢0.1. The peptides are contained within Mb1438c/Rv1403c
(pool 1), Mb1440c/Rv1405c (pools 6 and 8), FadD21 (pool 25)
and FadE24 (pool 32).
Fig. 4. Growth phenotype of the M. tuberculosis PG100 triple
mutant. The growth of the M. tuberculosis H37Rv wild-type plus
pMD31 empty vector (&), PG100 mutant with pMD31 vector (m),
and complemented mutants (., $) is shown. Complementation of
PG100 with plasmid pPG72 (.), which contained the Rv1403c-
Rv1404-Rv1405c genes deleted from PG100, or with pPG57
($), containing just the Rv1404 regulator, failed to restore the
growth of the mutant to wild-type levels. Data shown are from one
experiment, representative of three.
M. tuberculosis methyltransferases
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Several plasmid constructs consisting of DNA fragments
containing native operator-promoter and coding sequences
of Rv1405c, Rv1404 and Rv1403c cloned into the multicopy
plasmid pMD31 were constructed (see Methods and Fig. 1)
and introduced into PG100. The level of expression of
Rv1405c was found to be over 700-fold higher in PG100
carrying the Rv1405c construct pPG53 than the wild-type
strain (Table 3), suggesting that the product of Rv1404,
absent in the mutant, represses the transcription of
Rv1405c. Based on the assumption that there are 5–10
copies of pMD31 per cell in mycobacteria (Donnelly-Wu et
al., 1993), one can estimate that the expression of Rv1405c
in a DRv1404 background is approximately 70–150-fold
higher than in the wild-type. Evidence to support the
proposed repressor role of Rv1404 on the expression of
Rv1405c was provided by the finding that the expression of
Rv1405c in PG100 carrying the plasmid pPG55, which
contains both Rv1405c and Rv1404, is 45-fold less than the
mutant carrying pPG53. Expression of Rv1403c was also
found to be 37.7-fold higher in PG100 carrying the
Rv1403c-containing pPG54 compared to the wild-type,
but only 3.4-fold higher in PG100 carrying both Rv1403c
and Rv1404 (pPG56). This suggests that Rv1404 represses
the transcription of both Rv1405c and Rv1403c, but the
lower fold induction levels of Rv1403c in the mutant would
suggest that the promoter of Rv1403c is weaker than that of
Rv1405c.
Transcriptome analysis of PG100
The growth defect of the PG100 DRv1405c–Rv1403c triple
mutant could be partially reversed by complementing with
the Rv1404 regulator, suggesting that Rv1404 regulated
genes in addition to Rv1405c and Rv1403c, genes that may
include the methylation target of Rv1403c and Rv1405c. In
order to identify these genes, DNA microarrays were used
to compare the transcriptional profiles of the wild-type
H37Rv and PG100. Table 4 shows the fold changes in
expression for 28 genes that showed a minimum 3-fold
differential expression in PG100 compared with H37Rv.
Introduction of a plasmid overexpressing Rv1404, pPG57,
into the mutant strain reduced the expression of 25 of the
28 differentially expressed genes to levels that were similar
(,2-fold difference) to those seen in the wild-type.
Twenty-two of the 25 Rv1404-regulated genes were
upregulated in PG100, suggesting that Rv1404 is predom-
inantly a transcriptional repressor.
Six of the twenty-seven genes identified as showing a 3-fold
or greater difference in expression between the wild-type
and the mutant were selected, based on putative function
and fold change, for analysis by qRT-PCR. Fig. 5 shows
that the fold changes in expression measured by microarray
and qRT-PCR for these six genes are comparable,
validating the results of the microarray analysis.
DISCUSSION
There is a critical need for new tools for the control of both
M. bovis and M. tuberculosis infection and disease. We have
used a combination of global gene expression studies and
antigen mining to identify novel antigens of M. bovis. We
have also moved this applied research back to a more
fundamental setting, identifying the regulatory network
that controls the expression of the two most promising
antigens we identified. We believe that this combination of
applied and fundamental research offers the best chance to
accelerate the generation of new control tools.
Two of the most highly upregulated genes in response to in
vitro acid shock, the methyltransferase-encoding genes
Rv1403c/Mb1438c and Rv1405c/Mb1440c, were also found
to be highly upregulated in vivo. The expression of
Mb1440c in vivo was particularly high, showing an
approximately 350-fold higher level of expression com-
pared to an in vitro control. This level of induction is
comparable to the 70–150-fold induction of Rv1405c seen
in an DRv1404 mutant background compared to the wild-
type, suggesting that Rv1405c/Mb1440c expression was
completely derepressed in infected mouse lung tissues.
Expression of Mb1440c/Rv1405c and Mb1438c/Rv1403c was
shown to be tightly regulated by the product of the
Mb1439/Rv1404 gene, encoding a member of the MarR
family of transcriptional regulators (Ellison & Miller, 2006;
Grkovic et al., 2002). Mb1440c/Rv1405c and Mb1438c/
Rv1403c showed very low expression under in vitro non-
stressed and ex vivo conditions, but high expression under
in vivo and stressed in vitro conditions. It is noteworthy
that in Mycobacterium ulcerans a transposon is inserted in
the promoter/operator region of the Mb1439/Rv1404
orthologue (Stinear et al., 2007), presumably resulting in
constitutive expression of the Rv1405c orthologue since its
protein product was detected in the cytoplasmic fraction of
M. ulcerans by LC-MS (annotated at http://genolist.pas-
teur.fr/BuruList/).
The majority of MarR regulators act as repressors, and
their activity can be modulated through binding of an
inducer molecule to the MarR regulator (Ellison & Miller,
2006; Grkovic et al., 2002). Genes regulated by MarR
family members are repressed in the absence of the inducer
and derepressed in the presence of inducer. Many MarR
Table 3. Effect of Rv1404 on the expression of Rv1405c and
Rv1403c measured by real-time qRT-PCR
Gene expression values are relative to those in the wild-type.
Plasmid in PG100 Rv1405c Rv1404 Rv1403c
pPG53 739.0 ND ND
pPG54 ND 9.0 37.7
pPG55 16.4 7.8 ND
pPG56 ND 10.0 3.4
ND, Not detected.
P. Golby and others
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repressors are also autoregulatory, repressing their own
expression in the absence of inducer. This would explain
the observed moderate increase (3–4-fold) in expression of
Mb1439/Rv1404 observed under acidic and in vivo condi-
tions, as the regulator would be unable to bind to its
operator and repress its own expression. In addition to
Rv1405c and Rv1403c, deletion of Rv1404 was also shown
to affect the expression of another 25 genes, 10 of which
were previously shown to be upregulated in response to
acid shock in M. tuberculosis H37Rv. This suggests that
Rv1404/Mb1439 is an important regulator in the response
of M. tuberculosis and M. bovis to acid shock. Curiously, the
three genes that show the highest induction in the Rv1404
mutant (Rv0193c–Rv0195) show no upregulation in
response to acid (Golby et al., 2007), suggesting that the
expression of these genes could be regulated by other
factors in addition to Rv1404.
In a seminal study, Sassetti and Rubin used a combination
of saturation mutagenesis with in vivo selection to identify
M. tuberculosis genes that were required for survival in a
mouse infection model; Rv1405c was among the 197 genes
identified as important for virulence (Sassetti & Rubin,
2003). Hence, methylation of Rv1405c’s target is involved
in virulence. There are a number of examples where
methylation of mycobacterial cellular components has been
implicated in the virulence of M. tuberculosis. Methylation
of the mycobacterial heparin-binding haemagglutinin
adhesin (HBHA), an extrapulmonary dissemination factor
(Pethe et al., 2001), is required for T-cell immunity and
protects the molecule against proteolysis (Pethe et al., 2002;
Temmerman et al., 2004). Similarly, cyclopropanation of
mycolic acids by pcaA and cmaA2 has been shown to be
involved in virulence of M. tuberculosis (Glickman et al.,
2000; Rao et al., 2006). Overexpression of Rv1405c in M.
smegmatis mc2155 caused no significant changes in mycolic
acid profile (data not shown), suggesting that Rv1405c is
not involved in cyclopropanation of mycolic acids. Analysis
of the Rv1405c locus reveals genes encoding formyl
methionine transferase (fmt) and a putative rRNA
methyltransferase (fmu), suggesting that Rv1405c/Rv1403c
could be involved in methylating a component of the
Table 4. Gene expression control by Rv1404
Rv no. Gene Product Fold change*
Wild-type vs PG100 Wild-type vs PG100(pPG57)
Rv0193c Hypothetical protein 30.1 NC
Rv0194 ABC transporter 13.1 NC
Rv0195 Transcriptional regulator 52.7 NC
Rv0341 iniB Isoniazid-inducible gene 4.0 4.0
Rv0575cD Possible oxidoreductase 6.0 NC
Rv1376 Conserved hypothetical protein 7.7 NC
Rv1392D metK AdoMet synthase 4.1 NC
Rv1402 priA Putative primosomal protein 6.3 NC
Rv1592c Conserved hypothetical protein 4.0 4.4
Rv1620c cydC Cytochrome transporter assembly protein 0.31 NC
Rv1623c cydA Cytochrome transporter assembly protein 0.30 NC
Rv1682D Coiled-coil protein 10.9 NC
Rv1809D PPE33 PPE family protein 3.0 NC
Rv2281 pitB1 Phosphate transporter 3.5 NC
Rv2322cD rocD1 Ornithine aminotransferase 3.6 NC
Rv2389cD rpfD Resuscitation factor 5.8 NC
Rv2390cD Conserved hypothetical protein 8.6 NC
Rv2700 Possible secreted protein 4.4 NC
Rv2817c Conserved hypothetical protein 0.32 NC
Rv2930 fadD26 Fatty acid synthase 3.7 NC
Rv2934 ppsD Polyketide synthase 3.9 4.7
Rv3137 Probable monophosphatase 3.1 NC
Rv3289c Possible transmembrane protein 3.1 NC
Rv3371D Conserved hypothetical protein 4.1 NC
Rv3531c Hypothetical protein 3.2 NC
Rv3532D PPE61 PPE family protein 10.2 NC
Rv3533c PPE62 PPE family protein 3.3 NC
Rv3746cD PE34 PE family protein 3.9 NC
*NC, No change.
DGenes shown previously to be 3-fold or more upregulated in M. tuberculosis H37Rv in response to acid.
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protein translational machinery; however, how this would
play a role in virulence is unknown.
The DRv1403c-Rv1404-Rv1405c mutant also showed upre-
gulation of distal genes. Rv0193c–Rv0195 showed the highest
degree of upregulation (13–52-fold), and their contiguity
suggests that their products could be functionally related.
Rv0195 encodes a response regulator of the two-component
family and, like Rv1403c and Rv1405c, has been shown to be
upregulated in response to low oxygen conditions
(Muttucumaru et al., 2004; Voskuil et al., 2004). The gene
Rv0194 encodes a putative ABC-type transporter, but its
function and substrate are unknown. The gene is unique
amongst other ABC-type transporters of M. tuberculosis in
having two membrane-spanning domains and two nucleo-
tide-binding domains in a single polypeptide.
In summary, on an applied level we have defined novel M.
bovis antigens that are now being moved forward to larger
field trials. On a fundamental level, we have described the
regulation of genes encoding two methyltransferases in M.
tuberculosis, one of which, Rv1405c, has been implicated as
a virulence factor. The next step will be to identify the
target(s) of these methyltransferases to elucidate their role
in virulence.
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